Overview
Spongiform encephalopathy encompasses transmissible spongiform encephalopathies (TSEs) such as classical BSE (C-BSE) and atypical L-type BSE (L-BSE), affecting various species including goats and cattle, with potential zoonotic risks. 15Diagnosis
Clinical features include skin lesions, alopecia, and abnormal mental status in affected animals. 1
Histological examination and immunohistochemistry differentiate between C-BSE and L-BSE strains. 1
Detection methods for central nervous tissue (CNT) markers like GFAP and NSE in meat products can aid in identifying potential contamination risks. 2Management
No specific treatments exist for spongiform encephalopathy; management focuses on supportive care. 5
Monitoring vital signs and cardiovascular responses, noting increased blood pressure in affected cattle, may guide supportive interventions. 4Special Populations
No specific guidance provided for pregnancy, pediatrics, or elderly populations in the abstracts. 145Key Recommendations
Implement rigorous monitoring and surveillance programs for TSEs in small ruminants to detect both classical and atypical strains early. (Evidence: Moderate) 1
Utilize advanced detection methods, such as GC/MS for CNT markers, to ensure compliance with bans on specified risk materials in food products. (Evidence: Moderate) 2
Exercise caution with sedative administration in cattle suspected of having BSE due to altered responses, particularly noting prolonged sedation times and elevated blood pressure. (Evidence: Weak) 4
Continue research to clarify the zoonotic potential of BSE and refine protective measures for workers exposed to cattle. (Evidence: Expert opinion) 5References
1 Vallino Costassa E, D'Angelo A, Mazza M, Meloni D, Baioni E, Maurella C et al.. Clinical, pathological, and molecular features of classical and L-type atypical-BSE in goats. PloS one 2018. link
2 Lücker E, Biedermann W, Alter T, Hensel A. GC/MS detection of central nervous tissue as specified BSE risk material in meat products and meat and bone meals: thermal stability of markers in comparison with immunochemistry and RT-PCR. Analytical and bioanalytical chemistry 2010. link
3 Dyer C. "Unprecedented" row delays second phase of BSE inquiry. BMJ (Clinical research ed.) 1999. link
4 Braun U, Abgottspon S, Gubler E, Schweizer T. Decreased sedation by xylazine and high blood pressure in cows with BSE. The Veterinary record 1999. link
5 Hodgson E. BSE. An unlikely zoonosis. Occupational health; a journal for occupational health nurses 1990. link